Related Experiment Video
Updated: Sep 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Low-density lipoprotein apheresis in the treatment of peripheral arterial disease
1Department of Blood Purification and Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan. akawa@kc.twmu.ac.jp
Insights
Low-density lipoprotein (LDL) apheresis effectively treats familial hypercholesterolemia by removing LDL cholesterol. This procedure alleviates angina, improves coronary lesions, and enhances peripheral circulation in patients with arteriosclerosis.
Area of Science:
- Cardiology
- Vascular Biology
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) involves LDL receptor deficiency, leading to severe hypercholesterolemia.
- Homozygous FH patients lack LDL receptors, while heterozygous FH patients have reduced function.
- Resistant hypercholesterolemia necessitates advanced treatment strategies.
Purpose of the Study:
- To evaluate the efficacy of low-density lipoprotein (LDL) apheresis in managing severe hypercholesterolemia.
- To assess the impact of LDL apheresis on cardiovascular symptoms and lesions.
- To investigate the effects of LDL apheresis on peripheral blood flow and rheology.
Main Methods:
- LDL apheresis procedure to selectively remove LDL cholesterol from the blood.
- Assessment of anginal symptoms and coronary lesion progression.
- Evaluation of peripheral blood flow and blood rheology parameters.
Main Results:
- LDL apheresis significantly reduces LDL cholesterol levels.
- The procedure alleviates anginal symptoms and can improve coronary artery lesions.
- Improved peripheral blood flow and enhanced blood rheology were observed.
Conclusions:
- LDL apheresis is a valuable therapeutic option for patients with severe familial hypercholesterolemia and resistant hypercholesterolemia.
- The benefits extend to improving cardiovascular health and peripheral circulation.
- Consideration for LDL apheresis in patients with arteriosclerotic lesions, including normocholesterolemic individuals, is warranted.
Abstract:
Low-density lipoprotein (LDL) apheresis is performed in patients with homozygous familial hyper-cholesterolemia who lack LDL receptors and with heterozygous familial hypercholesterolemia who are LDL receptor deficient with documented, symptomatic coronary artery disease who are resistant to diet changes and maximum drug therapy. LDL apheresis can reduce or abolish anginal symptoms and improve coronary lesions. Several reports reveal the improvement of insufficient peripheral blood flow. By extensively removing blood LDL and changing coagulation factors and various vasoactive substances, LDL apheresis improves blood rheology and thereby peripheral circulation. It seems worth trying on all patients with arteriosclerotic lesions, even if they are normocholesterolemic.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

